Open AccessSuccessful fractionated undiluted doses of COVID ‐19 vaccine in five cases of suspected allergic reactions to the first dose
Author(s) -
Rivolta Federica,
Camilla Cappelletti,
Sangalli Andrea,
Chiei Gallo Alessandra,
Pravettoni Valerio
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.6348
Subject(s) - medicine , premedication , antihistamine , peg ratio , covid-19 , in vivo , allergic reaction , pharmacology , allergy , anesthesia , immunology , microbiology and biotechnology , disease , finance , infectious disease (medical specialty) , economics , biology
After a suspected allergic reaction to first dose of mRNA COVID‐19 vaccine, given the PEG skin tests negativity and tolerance in vivo to PEG containing drugs, five patients were vaccinated with the second dose of Pfizer‐Biontech undergoing a fractional protocol, with antihistamine premedication, without presenting immediate or delayed reactions.